Skip to main content
. 2020 Mar 16;26:102246. doi: 10.1016/j.nicl.2020.102246

Table 1.

Characteristics of study population by group

PHIV (n = 40) PING (n = 80) p-value
Female (n(%)) 21 (53%) 40 (50%) 0.80
Age (mean (SD)) 16.7 (2.4) 16.3 (2.8) 0.66
Race (n(%)) 0.44
 Black 29 (73%) 52 (65%)
 White 10 (25%) 28 (35%)
Hispanic ethnicity (n(%)) 5 (13%) 10 (13%) 1.00
Caretaker education (n(%))a 0.35
 Less than high school 7 (18%) 8 (10%)
 High School or GED 13 (33%) 28 (35%)
 Some college or 2 year degree 10 (25%) 25 (31%)
 4 year college 3 (7.5%) 12 (15%)
 Graduate School 7 (18%) 7 (8.8%)
Annual household income (n(%))b 0.52
 Less than 10000 2 (5%) 5(6.3%)
 10001–20000 10 (25%) 11 (14%)
 20001–30000 6 (15%) 14 (18%)
 30001–40000 6 (15%) 14 (18%)
 40001–50000 3 (7.5%) 3 (3.8%)
 50001–100000 11 (28%) 21 (26%)
 greater than 100000 2 (5%) 12 (15%)
HIV disease-severity measures (median (Q1, Q3) or N (%) for PHIV
 CD4% < 15% 17 (43%)
 Nadir CD4% 16.5 (8.0,23.8)
 Age (years) at nadir CD4% 5.7 (2.2,10.9)
 Nadir CD4 count 236.0 (112.0, 392.5)
 Age (years) at nadir CD4 count 8.2 (3.8, 11.6)
 Most recent* CD4 count 627 (453.0, 846.0)
 Most recent* CD4% 35.9 (27.6,42.9)
 Age (years) at most recent CD4%/CD4 count 17.0 (14.9,18.2)
 Log peak HIV RNA viral load (copies/mL) 5.7 (5.2,5.9)
 Age (years) at peak RNA 2.5 (0.6,5.3)
 Most recent* RNA count > 400 copies/mL 6 (15)
 Age (years) at most recent RNA 17.0 (14.9, 18.2)
 % of viral load > 1000 copies/mL in past 5 years 6.5 (0.0, 29.0)
 Age at start of cART 3.5 (1.4 -6.3)
 ARV regimen at the time of scan
  cART 37(92%)
  Not on cART 1 (3%)
  Not on any antiretrovirals 2 (5%)
 CDC ‘C’ Classification 9 (22%)

GED = General Education Development test passed.

Cart = combination antiretrovial therapy (regimen including at least 3 drugs from at least 2 drug classes).

CDC = Centers for Disease Control.

Most recent = closest clinical data to neuroimaging scan.

a

One missing value of PING subjects imputed.

b

Eleven missing values of PING subjects imputed.